Travere Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
Go back to Travere Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results| (NASDAQ: TVTX) | Delayed: 62.76 -1.98 (3.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.74 | 52 Week High | $ | |||
| Open | $64.89 | 52 Week Low | $ | |||
| Day High | $64.89 | P/E | N/A | |||
| Day Low | $62.47 | EPS | $ | |||
| Volume | 2,235,856 | |||||

